Sherif Farag
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Azacitidine Plus Nivolumab Following Reduced-intensity Allogeneic PBSC Transplantation for Patients With AML and High-risk Myelodysplasia (NCT04128020) | Sherif Farag | 2019-10-10 |
Track Sherif Farag automatically
Every clearance here is in the API, with alerts when new ones post.